外周动脉疾病中的骨骼肌质量与质量:临床管理与治疗优化的新见解
本文为叙述性综述,聚焦外周动脉疾病(PAD)相关缺血性肌病的病理机制、肌肉质量与质量的评估方法及当前保留或恢复肌肉健康的策略。综述指出,慢性缺血通过线粒体功能障碍、氧化应激、纤维类型转变、蛋白水解和合成抵抗等机制导致肌肉萎缩与质量退化;评估从踝肱指数和功能筛查开始,可选节段生物阻抗或床旁超声,必要时CT或MRI。治疗上,血运重建恢复灌注为康复创造条件,但不足以确保肌肉改善;包含抗阻训练的运动优于仅耐力训练,传统PAD药物对肌肉直接作用有限。
要点
- PAD慢性缺血导致线粒体功能障碍、氧化应激和蛋白水解,引发肌肉萎缩与质量退化。
- 肌肉评估从ABI和功能筛查开始,可选生物阻抗或超声,必要时CT/MRI。
- 包含抗阻训练的运动比仅耐力训练更能维持肌肉质量与质量。
核心结论
- 将骨骼肌视为治疗靶点,支持结合血运重建、包含抗阻训练的运动、营养优化和新兴肌肉导向疗法的综合管理,以改善活动能力和临床结局。
研究设计与样本
- 叙述性综述,针对PAD相关肌肉病理、肌肉质量与质量的评估方法及当前保留或恢复肌肉健康的策略进行临床导向的综合。
主要发现
- 慢性缺血损害线粒体生物发生,增加活性氧,激活泛素-蛋白酶体和自噬-溶酶体途径,抑制IGF-1/Akt/mTOR信号,导致肌肉萎缩和质量退化。
- 内皮功能障碍和促炎巨噬细胞极化进一步限制再生。
- 仅耐力运动可能不足以保留肢体肌肉,而包含抗阻训练的运动更好地维持肌肉质量和质量。
- 血运重建恢复灌注并减轻缺血,从而为康复驱动的骨骼肌和功能恢复创造生理环境,但本身不确保改善。
- 传统PAD药物降低血管风险,但对肌肉的直接作用有限;基于机制的疗法仍在研究中。
临床怎么用
- 评估从踝肱指数和功能筛查开始,随后可选节段生物阻抗或床旁超声,选择性使用CT或MRI。
- 运动方案应包含抗阻训练以更好维持肌肉质量和质量,而非仅耐力训练。
- 血运重建后应结合康复训练以促进骨骼肌和功能恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral artery disease (PAD) induces chronic limb ischemia that affects downstream skeletal muscle and leads to ischemic myopathy. Chronic ischemia results in mitochondrial dysfunction, oxidative stress, fiber-type shift, proteolysis, and anabolic resistance, contributing to reduced endurance and persistent weakness despite revascularization. METHODS: This narrative review provides a clinically oriented synthesis of PAD-related muscle pathology, pragmatic approaches to assessing muscle mass and quality, and current strategies to preserve or restore muscle health. RESULTS: Chronic ischemia impairs mitochondrial biogenesis, increases reactive oxygen species, activates ubiquitin-proteasome and autophagy-lysosome pathways, and suppresses IGF-1/Akt/mTOR signaling, resulting in muscle atrophy and qualitative degeneration. Endothelial dysfunction and pro-inflammatory macrophage polarization further limit regeneration. Assessment begins with the ankle-brachial index and functional screening, followed by segmental bioimpedance or bedside ultrasound, with selective computed tomography or magnetic resonance imaging. Although exercise improves walking performance, endurance-only programs may inadequately preserve limb muscle, whereas resistance-inclusive training better maintains muscle mass and quality. Revascularization restores perfusion and mitigates ischemia, thereby preparing a physiological environment that supports, but does not by itself ensure, rehabilitation-driven improvements in skeletal muscle and functional recovery. Conventional PAD drugs reduce vascular risk but show limited direct muscle effects; mechanism-based therapies remain investigational. CONCLUSION: Recognizing skeletal muscle as a therapeutic target supports an integrated management approach combining revascularization, resistance-inclusive exercise, nutritional optimization, and emerging muscle-directed therapies to improve mobility and clinical outcomes.
引用
- Nishibe T, Kano M, Fukuda S, et al. Skeletal Muscle Mass and Quality in Peripheral Artery Disease: New Insights into Clinical Management and Therapeutic Optimization. Ann Vasc Surg. 2026. PMID: 41796661. doi:10.1016/j.avsg.2026.02.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。